Document is current
Any future updates will be listed below
-
Authors
Overbey, Eliah G. http://orcid.org/0000-0002-2866-8294
Ryon, Krista
Kim, JangKeun http://orcid.org/0000-0002-8733-9925
Tierney, Braden T. http://orcid.org/0000-0002-7533-8802
Klotz, Remi http://orcid.org/0000-0003-2100-0635
Ortiz, Veronica
Mullane, Sean
Schmidt, Julian C.
MacKay, Matthew
Damle, Namita
Najjar, Deena http://orcid.org/0009-0009-7950-2866
Matei, Irina http://orcid.org/0000-0002-5712-8430
Patras, Laura
Garcia Medina, J. Sebastian
Kleinman, Ashley S.
Wain Hirschberg, Jeremy
Proszynski, Jacqueline
Narayanan, S. Anand
Schmidt, Caleb M.
Afshin, Evan E.
Innes, Lucinda
Saldarriaga, Mateo Mejia
Schmidt, Michael A.
Granstein, Richard D.
Shirah, Bader http://orcid.org/0000-0001-6493-2155
Yu, Min
Lyden, David http://orcid.org/0000-0003-0193-4131
Mateus, Jaime
Mason, Christopher E. http://orcid.org/0000-0002-1850-1642
-
Funding
Funding for this research was provided by:
WorldQuant Foundation
- License Information
-
More Information
Article History
Received: 2 May 2023
Accepted: 15 May 2024
First Online: 11 June 2024
Competing interests
: CEM is co-Founder of Cosmica Biosciences. BTT is compensated for consulting with Seed Health and Enzymetrics Biosciences on microbiome study design and holds an ownership stake in the former. CMS, JCS, and MAS hold shares in Sovaris Holdings, LLC. MY is the founder and president of CanTraCer Biosciences Inc. Authors not listed here do not have competing interests.
